Just a month after announcing a deal with Eli Lilly to work on RNAi drugs for metabolic diseases, China’s SanegeneBio has disclosed a $110 million Series B round to fund its …
Investors buy up stocks in biggest follow-on offering day in biotech history
A record-setting $3.2 billion in biotech follow-on stock offerings were sold over the last 24 hours, another indication of public investors’ appetite for the sector.



